Mohs Surgery Specialists Llc

CLIA Laboratory Citation Details

3
Total Citations
20
Total Deficiencyies
9
Unique D-Tags
CMS Certification Number 19D1031513
Address 4950 Essen Lane, Suite 301, Baton Rouge, LA, 70809
City Baton Rouge
State LA
Zip Code70809
Phone(225) 763-9611

Citation History (3 surveys)

Survey - June 23, 2025

Survey Type: Standard

Survey Event ID: F9BU11

Deficiency Tags: D0000 D5429 D5429 D6095 D6095

Summary:

Summary Statement of Deficiencies D0000 A Recertification survey was performed at Mohs Surgery Specialists, LLC, CLIA ID 19D1031513, on June 23, 2025. The laboratory was found in compliance with 42 CFR 493 Requirements for Laboratories; however, standard level deficiencies were cited. D5429 MAINTENANCE AND FUNCTION CHECKS CFR(s): 493.1254(a)(1) (a)(1) Maintenance as defined by the manufacturer and with at least the frequency specified by the manufacturer. This STANDARD is not met as evidenced by: Based on observation by surveyor, review of the manufacturer's instrument manual, the laboratory's maintenance records, and interview with personnel, the laboratory failed to perform the preventative maintenance (PM) annually for the two (2) Leica cryostats for two (2) of two (2) years reviewed. Findings: 1. Observation by surveyor during the laboratory tour on June 23, 2025 at 9:54 am revealed the laboratory utilized two (2) Leica cryostats for Mohs (Histopathology) testing. 2. Review of the Leica instrument manual under the "Cleaning and maintenance" section revealed "Have the instrument inspected by a qualified service engineer authorized by Leica at least once a year." 3. Review of the laboratory's maintenance records for the cryostats revealed the annual PM for 2023 and 2024 were not performed. 4. In interview on June 23, 2025 at 11:23 am, Histotech 1 stated she could not find the PM documentation for 2023. Histotech 1 also stated the PM was performed in January 2025, not in 2024. D6095 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(e)(6) (e)(6) Ensure the establishment and maintenance of acceptable levels of analytical performance for each test system; Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- This STANDARD is not met as evidenced by: Based on observation by surveyor, review of the manufacturer's instrument manual, the laboratory's maintenance records, and interview with personnel, the Laboratory Director failed to ensure maintenance procedures were followed to ensure acceptable levels of test performance. Refer to D5429. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - September 8, 2023

Survey Type: Standard

Survey Event ID: ON7J11

Deficiency Tags: D0000 D5415 D5417 D6087 D6087 D0000 D5415 D5417 D6107 D6107

Summary:

Summary Statement of Deficiencies D0000 A Certification survey was performed on September 8, 2023 at Mohs Surgery Specialists, LLC, CLIA ID 19D1031513. The laboratory was found in compliance with 42 CFR 493 Requirements for Laboratories; however, standard level deficiencies were cited. D5415 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(c) Reagents, solutions, culture media, control materials, calibration materials, and other supplies, as appropriate, must be labeled to indicate the following: (1) Identity and when significant, titer, strength or concentration. (2) Storage requirements. (3) Preparation and expiration dates. (4) Other pertinent information required for proper use. This STANDARD is not met as evidenced by: Based on observation by surveyor and interview with personnel, the laboratory failed to label marking dyes stored in secondary containers with the identity, expiration date, and applicable storage information. Findings: 1. Observation by surveyor during the laboratory tour on September 8, 2023 at 9:30 am revealed the laboratory stored smaller bottles of marking dyes in four (4) procedure rooms. 2. In interview on September 8, 2023 at 9:48 am, Histotech #1 stated the smaller bottles of marking dyes were filled from larger (master) bottles located in another room. 3. Further observation by surveyor during the laboratory tour revealed the smaller bottles of marking dyes were not labeled with the lot, expiration dates, and applicable information of the master bottles. 4. In further interview on September 8, 2023 at 9:48 am, Histotech #1 confirmed the smaller marking dyes were not labeled with the master marking dye bottle's information. D5417 TEST SYSTEMS, EQUIPMENT, INSTRUMENTS, REAGENT CFR(s): 493.1252(d) Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- Reagents, solutions, culture media, control materials, calibration materials, and other supplies must not be used when they have exceeded their expiration date, have deteriorated, or are of substandard quality. This STANDARD is not met as evidenced by: Based on observation by surveyor, review of policies, quality assessment records, and interview with personnel, the laboratory failed to ensure marking dyes did not exceed their expiration dates. Findings: 1. Observation by surveyor during laboratory tour on September 8, 2023 at 9:30 am revealed the following expired items: a) Stat Lab Blue Margin Marker, Lot 39834, Expiration date: 3/2017, Quantity: One (1) bottle b) Cancer Diagnostics, CDI, Blue tissue marking dye, Lot 21069, Expiration date: 2023- 03-31, Quantity: one (1) bottle c) Cancer Diagnostics, CDI, Red tissue marking dye, Lot 9094, Expiration date: 2021-04-01, Quantity: one (1) bottle d) Cancer Diagnostics, CDI, Black tissue marking dye, Lot 9150, Expiration date: 2021-05-01, Quantity: two (2) bottles 2. Review of the laboratory's "Mohs Statement of Policy and Procedure" under the "Quality Control" section revealed "All reagents are used within the expiration date. Expired reagents are discarded." 3. Review of the laboratory's "Monthly Internal QA" revealed the laboratory performs a monthly check for "expired chemicals". 4. In interview on September 8, 2023 at 9:48 am, Histotech #1 stated the laboratory checks for expired chemicals monthly, which did not include the marking dyes as they did not consider those to be laboratory related supplies. Histotech # 1 confirmed the identified items were expired. D6087 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(e)(3)(iii) The laboratory director must ensure that laboratory personnel are performing the test methods as required for accurate and reliable results. This STANDARD is not met as evidenced by: Based on observation by surveyor and interview with personnel, the Laboratory Director failed to ensure the laboratory personnel performed test methods as required. Findings: 1. The laboratory failed to label marking dyes stored in secondary containers with the identity, expiration date, and applicable storage information. Refer to D5415. 2. The laboratory failed to ensure marking dyes did not exceed their expiration dates. Refer to D5417. D6107 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(e)(15) The laboratory director must specify, in writing, the responsibilities and duties of each consultant and each supervisor, as well as each person engaged in the performance of the preanalytic, analytic, and postanalytic phases of testing, that identifies which examinations and procedures each individual is authorized to perform, whether supervision is required for specimen processing, test performance or result reporting and whether supervisory or director review is required prior to reporting patient test results. This STANDARD is not met as evidenced by: -- 2 of 3 -- Based on record review and interview with personnel, the Laboratory Director failed to include written description of duties and responsibilities of personnel involved in all phases of testing. Findings: 1. Review of the laboratory's documents and personnel records revealed the laboratory did not have written job responsibilities for the following: Laboratory Director Clinical Consultant Technical Supervisor General Supervisor Testing Personnel 2. In interview on September 8, 2023 at 10:48 am, Histotech # 1 confirmed the laboratory did not have written job descriptions for the identified roles that the Laboratory Director serves as. -- 3 of 3 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - July 22, 2019

Survey Type: Standard

Survey Event ID: BIVV11

Deficiency Tags: D5401 D5401 D0000 D6093 D6093

Summary:

Summary Statement of Deficiencies D0000 A Certification Survey was performed on July 22, 2019 at Mohs Surgery Specialist, LLC, CLIA ID # 19D1031513. The laboratory was found in compliance with 42 CFR 493 Requirements for Laboratories; however, standard level deficiencies were cited. D5401 PROCEDURE MANUAL CFR(s): 493.1251(a) A written procedures manual for all tests, assays, and examinations performed by the laboratory must be available to, and followed by, laboratory personnel. Textbooks may supplement but not replace the laboratory's written procedures for testing or examining specimens. This STANDARD is not met as evidenced by: Based on record review and interview with personnel, the laboratory failed to follow their established quality control procedure. Findings: 1. Review of the laboratory's "Mohs Statement of Policy and Procedure" under the "Quality Control" section revealed "The Mohs surgeon/director reviews the slides and checks off for quality of section, stain, and coverslipping." 2. Review of the laboratory's "Stain Lot Numbers" form revealed quality control was documented; however, it did not indicate the Laboratory Director performed the review. 3. Review of random selection of patient reports and quality control records revealed the laboratory did not have documentation the Laboratory Director reviewed the quality of the slides for the following dates: December 20, 2017 July 31, 2018 October 11, 2018 December 31, 2018 February 6, 2019 March 18, 2019 June 6, 2019 July 2, 2019 4. In interview on July 18, 2019 at 10: 30 am, Personnel 2 stated she initial checks and documents the slide quality. Personnel 2 further stated the Laboratory Director reviews the slides after. Personnel 2 confirmed the "Stain Lot Numbers" form did not indicate the Laboratory Director, who serves as the Testing Personnel, reviewed the slide quality. D6093 LABORATORY DIRECTOR RESPONSIBILITIES Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- CFR(s): 493.1445(e)(5) The laboratory director must ensure that the quality control programs are established and maintained to assure the quality of laboratory services provided and to identify failures in quality as they occur. This STANDARD is not met as evidenced by: Based on record review and interview with personnel, the Laboratory Director failed to ensure that quality control programs for Histopathology were maintained. Refer to D5401. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access